Literature DB >> 6977439

Amphibian neurotensin (NT) is not xenopsin (XP): dual presence of NT-like and XP-like peptides in various amphibia.

R Carraway, S E Ruane, G E Feurle, S Taylor.   

Abstract

To clarify whether xenopsin (XP) is the amphibian counterpart of mammalian neurotensin (NT), extracts of skin, brain, and intestine from representative amphibians were subjected to immunochemical, chromatographic, and biological analyses. The results indicated the dual presence of NT- and XP-like peptides in extracts of tissues from Xenopus laevis, Rana catesbeiana, Rana pipiens, Bufo marinus, Bufo americanus, and Necturus maculosus, which were separated during gel chromatography on Sephadex G-25 and high pressure liquid chromatography on mu-Bondapak C-18. Immunochemical studies, employing three different region-specific antisera toward NT (ox and man) and one antiserum towards XP (Xenopus laevis), indicated that the NT-like peptides shared COOH-terminal homologies with NT and differed at their NH2-termini. TWo classes of NT-like peptides could be distinguished on the basis of their distributions in tissues and their cross-reactivities with the antisera; immunoreactive NT measured using antiserum HC-8 tended to be found primarily in brain and intestine, whereas that reactive with antiserum PGL-4 was most concentrated in stomach, liver, and pancreas. Although also present in brain and intestine, immunoreactive XP was highest in stomach, pancreas, and skin. Partially purified immunoreactive NT and XP obtained from gastrointestinal tissues of Xenopus laevis and Bufo marinus were shown to increase the hematocrit and induce cyanosis in anesthesized rats. These findings indicate the presence of both NT- and XP-like peptides in neural and gastrointestinal tissues from several amphibia and suggest the possibility that XP-like peptides (apart from NT) may exist in other animals.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6977439     DOI: 10.1210/endo-110-4-1094

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  9 in total

1.  Generation of xenopsin-related peptides from tissue precursors by media conditioned by endotoxin-stimulated rat peritoneal macrophages.

Authors:  D E Cochrane; R E Carraway; W Boucher
Journal:  Inflammation       Date:  1991-10       Impact factor: 4.092

2.  Species-specific effects of neurotensin on gallbladder contraction in vitro.

Authors:  Y S Guo; P Singh; J R Upp; J C Thompson
Journal:  Dig Dis Sci       Date:  1989-01       Impact factor: 3.199

Review 3.  Eye of newt and toe of frog: substance P and the charmed pot of neuropeptides.

Authors:  P Skrabanek
Journal:  Ir J Med Sci       Date:  1984-02       Impact factor: 1.568

4.  Evidence for the presence of xenopsin-related peptide(s) in the gastric mucosa of mammals.

Authors:  G E Feurle; R E Carraway; E Rix; W Knauf
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

5.  Xenopsin: the neurotensin-like octapeptide from Xenopus skin at the carboxyl terminus of its precursor.

Authors:  I Sures; M Crippa
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

6.  Localization of xenopsin and xenopsin precursor fragment immunoreactivities in the skin and gastrointestinal tract of Xenopus laevis.

Authors:  K C Sadler; C L Bevins; J C Kaltenbach
Journal:  Cell Tissue Res       Date:  1992-11       Impact factor: 5.249

7.  Development of Xenopus laevis skin glands producing 5-hydroxytryptamine and caerulein.

Authors:  T Seki; S Kikuyama; N Yanaihara
Journal:  Cell Tissue Res       Date:  1989-12       Impact factor: 5.249

8.  Biosynthesis and degradation of peptides derived from Xenopus laevis prohormones.

Authors:  M G Giovannini; L Poulter; B W Gibson; D H Williams
Journal:  Biochem J       Date:  1987-04-01       Impact factor: 3.857

9.  Xenopsin immunoreactivity in antral G-cells may reside in the N-terminus of gastrin 17.

Authors:  C F Johnston; C Shaw; J E Ardill; J M Sloan; K D Buchanan
Journal:  Histochemistry       Date:  1988
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.